Jay Rughani 🇺🇸
@JayRughani
Partner @a16z investing in healthcare technology. Prev @flatironhealth (acq by @roche for ~$2b) & @deloittehealth. Professional student.
Where do we most need AI in healthcare? To outline the most viable use cases for AI in healthcare today, we @a16z interviewed many of the largest healthcare orgs across the country. Here are the 19 areas we prioritized:
Congratulations to the one and only Scott Kupor. He is a world class leader, and I have no doubt that the country will be better off from his service. 🇺🇸
Thank you @realDonaldTrump for the opportunity to serve our country in helping @elonmusk, @VivekGRamaswamy and the entire DOGE team make efficiency a central tenet of the federal government truthsocial.com/@realDonaldTru…
Amazing oppy to do healthcare AI research w/ Dr Michael Moor, and it’s in Zurich!
Want to do a postdoc in my research group? bsse.ethz.ch/mail I can support one ETH Postdoc fellowship application this fall. For details, see: grantsoffice.ethz.ch/funding-opport… If interested, please carefully check your eligibility (esp PhD defense date) and then send us the…
Congrats to Tennr on raising their Series C from @IVP, @ICONIQCapital, @GVteam, @lightspeedvp, and us at @a16z. One-third of Americans are referred by their doctor for follow-up care each year. Each referral triggers a cascade of paperwork -- leading to missed patients,…
is AI scribing a commodity? best framework I've heard on this is from @pmarca: "Is it sugar or frosting?" - sugar: baked into the product, embedded intuitively in the user workflow, with a business model to match - frosting: simply layered on top of the product, leveraging…
The Queen of Capital Formation has spoken. Or is she actually @ArfurRock? 🤔
leak to @ArfurRock, raise $, announce on @tbpn - the new capital raising media stack 🤖
Congratulations to @omadahealth, for their recent listing day. 🔥 We've supported their mission since their early days and have witnessed their thoughtful approach to virtual care delivery through evidence-based programs and clinically-validated behavior change protocols.…
We asked @jkhamehl (GP @a16z) about the macro trends of VC as an asset class. "Traditional pools that didn't invest (sovereigns, big pensions) now want a seat at the table." "It's because the GDP % that's being taken over by tech has exploded." "NVIDIA, Apple, and Microsoft…
Drug design today remains a bespoke craft done through years of scientific trial-and-error. In order to develop a single approved therapy, medicinal chemists design and synthesize over 20,000 molecules -- balancing a drug’s potency with its properties of absorption, distribution,…
Congrats to my guy Morgan on a big and well deserved move!
some news! i've joined @BreyerCap as Partner and Head of Healthcare and Life Sciences.
Welcome @eriktorenberg !!
We are thrilled to welcome @eriktorenberg as a General Partner. More from @pmarca: bit.ly/4cC7lQ8
cool way to learn about ICHRA
very excited to announce...a new free course we're doing to explain how ICHRAs work! You've probably been hearing all about Individual Coverage Health Reimbursement Arrangement (if you're friendless and into health policy) But what does it actually look like in practice and…
5 secrets driving Deel’s ramp to $800m in revenue in 5 years:
Deel has grown from a cold start to over $800M of revenue in just five years. But how exactly did they do it? While they may look like a typical Silicon Valley story the truth is that @Bouazizalex and @shuoshuooshuooo have defied many SV conventions in their approach including…
1/ It's Time To Build: Healthtech Infrastructure 🛠️. In the “Maslow's hierarchy” of the healthcare industry’s needs, the infrastructure layer is the foundational workhorse of the system. Numerous (unfortunate) infra outages in recent years have shed light on the scale and…
Very excited here @a16zBioHealth for our partnership with @EliLillyandCo to collaboratively help the world's best innovators develop "new medicines, towards a new practice of medicine."
Our goals: New medicines. New practice of medicine. Our team: @a16z's global venture capital platform, together with @EliLillyandCo, the largest pharma company in the world. Go :) Excited about the opportunities ahead! cc @JorgeCondeBio @a16zBioHealth statnews.com/2025/01/10/eli…
Inspiring chart for startups. If AI enables a cost structure advantage (eg driverless cars), you can dislodge incumbents, perhaps even those “protected” by network effects as a moat.
Waymo's market share is now equal to Lyft within SF. Incredible. Network effects is one of the best sources of defensibility. But it's proven to be not that important in ridesharing. You need a minimum network size, but once you have that, there are diminishing returns. In…